Free Trial

Ekso Bionics (EKSO) Short Interest Ratio & Short Volume

Ekso Bionics logo
$0.63 -0.02 (-2.84%)
As of 01/21/2025 04:00 PM Eastern

Ekso Bionics Short Interest Data

Ekso Bionics (EKSO) has a short interest of 240,300 shares. This marks a 92.86% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 4.75 million shares to cover all short positions.

Current Short Interest
240,300 shares
Previous Short Interest
124,600 shares
Change Vs. Previous Month
+92.86%
Dollar Volume Sold Short
$146,583.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
21,998,000 shares
Percentage of Shares Shorted
1.09%
Today's Trading Volume
1,086,020 shares
Average Trading Volume
4,748,846 shares
Today's Volume Vs. Average
23%
Short Selling Ekso Bionics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Ekso Bionics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EKSO Short Interest Over Time

EKSO Days to Cover Over Time

EKSO Percentage of Float Shorted Over Time

Ekso Bionics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2024240,300 shares $146,583.00 +92.9%N/A0.3 $0.61
12/15/2024124,600 shares $70,610.82 +2.6%N/A1.3 $0.57
11/30/2024121,500 shares $84,442.50 +40.0%N/A1.5 $0.70
11/15/202486,800 shares $65,100.00 +17.6%N/A1.1 $0.75
10/31/202473,800 shares $63,172.80 -47.8%N/A0.9 $0.86
10/15/2024141,400 shares $149,884.00 -28.0%N/A1.6 $1.06
9/30/2024196,300 shares $227,708.00 +1.4%N/A2.2 $1.16
9/15/2024193,600 shares $237,160.00 -46.4%N/A2.2 $1.23
8/31/2024360,900 shares $433,080.00 +393.7%N/A4.3 $1.20
8/15/202473,100 shares $65,095.55 +52.0%N/A0.9 $0.89
7/31/202448,100 shares $50,505.00 -57.2%N/A0.7 $1.05
7/15/2024112,500 shares $154,125.00 -19.4%N/A2.1 $1.37
6/30/2024139,500 shares $147,172.50 +65.9%N/A2.2 $1.06
6/15/202484,100 shares $88,725.50 -28.4%N/A1.2 $1.06
5/31/2024117,500 shares $135,125.00 -27.7%N/A1.5 $1.15
5/15/2024162,600 shares $221,136.00 -26.9%N/A1.2 $1.36
4/30/2024222,300 shares $275,652.00 +16.8%N/A1.6 $1.24
4/15/2024190,300 shares $274,032.00 +41.7%N/A1.1 $1.44
3/31/2024134,300 shares $182,648.00 +20.8%N/A0.7 $1.36
3/15/2024111,200 shares $146,784.00 -23.4%N/A0.5 $1.32
2/29/2024145,100 shares $275,690.00 -15.7%N/A0.7 $1.90
2/15/2024172,100 shares $351,084.00 -32.0%N/A1 $2.04
1/31/2024253,000 shares $579,370.00 -32.2%N/A1.4 $2.29
1/15/2024373,300 shares $623,411.00 +44.8%N/A2.3 $1.67
12/31/2023257,900 shares $644,750.00 -13.9%2.2%2.1 $2.50
12/15/2023299,600 shares $401,464.00 +206.0%2.6%3.5 $1.34
11/30/202397,900 shares $171,325.00 +37.7%0.8%1.3 $1.75
11/15/202371,100 shares $98,829.00 +109.7%0.6%1 $1.39
10/31/202333,900 shares $36,951.00 -2.3%0.3%0.5 $1.09
10/15/202334,700 shares $26,996.60 -13.7%0.3%0.7 $0.78
9/30/202340,200 shares $29,466.60 -45.8%0.4%0.8 $0.73
9/15/202374,200 shares $53,898.88 +105.5%0.7%1.5 $0.73
8/31/202336,100 shares $32,500.83 +32.7%0.3%0.7 $0.90
8/15/202327,200 shares $29,648.00 -14.5%0.2%0.6 $1.09
7/31/202331,800 shares $36,888.00 -10.4%0.3%0.9 $1.16
7/15/202335,500 shares $42,955.00 -28.7%0.3%1.3 $1.21
6/30/202349,800 shares $71,214.00 +45.6%0.4%1.9 $1.43
6/15/202334,200 shares $46,512.00 -2.3%0.3%1.3 $1.36
5/31/202335,000 shares $47,250.00 -4.1%0.3%1.4 $1.35
5/15/202336,500 shares $59,860.00 +9.6%0.3%1.6 $1.64
Did You See Trump’s Manhattan Project Bombshell? (Ad)

This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.

4/30/202333,300 shares $49,617.00 -19.2%0.3%1.4 $1.49
4/15/202341,200 shares $64,684.00 +5.4%0.4%1.7 $1.57
3/31/202339,100 shares $64,515.00 -20.4%0.3%1.2 $1.65
3/15/202349,100 shares $69,722.00 +1.9%0.4%1.5 $1.42
2/28/202348,200 shares $68,926.00 -3.6%0.4%1.1 $1.43
2/15/202350,000 shares $85,900.00 -0.4%0.4%1 $1.72
1/31/202350,200 shares $84,838.00 -26.8%0.5%1 $1.69
1/15/202368,600 shares $121,422.00 +36.4%0.6%1.3 $1.77
12/30/202250,300 shares $59,857.00 -41.8%0.5%1 $1.19
12/15/202286,400 shares $120,096.00 +100.0%0.8%1.9 $1.39
11/30/202243,200 shares $44,928.00 -11.8%0.4%1.1 $1.04
11/15/202249,000 shares $63,700.00 -20.3%0.4%1.6 $1.30
10/31/202261,500 shares $101,475.00 -18.4%0.5%1.7 $1.65
10/15/202275,400 shares $107,068.00 -11.3%0.7%1.9 $1.42
9/30/202285,000 shares $132,600.00 -10.7%0.7%2.2 $1.56
9/15/202295,200 shares $205,632.00 +2.7%0.8%2 $2.16
8/31/202292,700 shares $217,845.00 +27.0%0.8%0.2 $2.35
8/15/202273,000 shares $181,770.00 -43.6%0.6%0.1 $2.49
7/31/2022129,400 shares $227,744.00 -4.3%1.1%0.2 $1.76
7/15/2022135,200 shares $229,569.60 -7.4%1.2%0.2 $1.70
6/30/2022146,000 shares $240,900.00 -77.7%1.3%0.3 $1.65
6/15/2022655,700 shares $1.23 million +1,322.3%5.6%1.2 $1.88
5/31/202246,100 shares $87,590.00 -20.5%0.4%1.1 $1.90
5/15/202258,000 shares $101,494.20 -11.3%0.5%1.3 $1.75
4/30/202265,400 shares $148,458.00 -15.5%0.6%1.5 $2.27
4/15/202277,400 shares $208,980.00 +14.8%0.7%1.8 $2.70
3/31/202267,400 shares $194,786.00 -3.3%N/A1.4 $2.89
3/15/202269,700 shares $179,826.00 +1.2%0.6%1.1 $2.58
2/28/202268,900 shares $179,140.00 -7.8%0.6%0.9 $2.60
2/15/202274,700 shares $194,220.00 -28.5%0.6%0.9 $2.60
1/31/2022104,400 shares $252,648.00 -11.1%0.8%1.1 $2.42
1/15/2022117,400 shares $297,022.00 +8.1%N/A1 $2.53
12/31/2021108,600 shares $287,790.00 -26.2%0.9%0.9 $2.65
12/15/2021147,100 shares $436,887.00 -11.0%1.2%1.4 $2.97
11/30/2021165,300 shares $537,225.00 -15.1%1.3%1.3 $3.25
11/15/2021194,800 shares $748,032.00 -3.6%1.6%1.6 $3.84
10/29/2021202,000 shares $812,040.00 +42.8%1.6%1.7 $4.02
10/15/2021141,500 shares $582,980.00 +9.7%1.1%1.4 $4.12
9/30/2021129,000 shares $595,980.00 -21.3%1.0%1.3 $4.62
9/15/2021164,000 shares $675,680.00 -8.6%1.3%1.6 $4.12
8/31/2021179,500 shares $858,010.00 -21.9%1.5%2.1 $4.78
8/13/2021229,800 shares $1.10 million -15.8%1.9%2.3 $4.79
7/30/2021272,900 shares $1.33 million +34.9%2.2%1.7 $4.86
7/15/2021202,300 shares $942,718.00 -4.9%1.6%1.1 $4.66
6/30/2021212,800 shares $1.17 million +33.2%1.7%0.9 $5.50
6/15/2021159,800 shares $872,508.00 -40.7%1.3%0.5 $5.46
5/28/2021269,500 shares $1.53 million -30.8%2.2%0.8 $5.68
5/14/2021389,300 shares $1.95 million -0.1%3.2%1.1 $5.02
4/30/2021389,800 shares $2.00 million +36.2%3.2%0.7 $5.12
4/15/2021286,200 shares $1.85 million +67.4%N/A0 $6.48
Did You See Trump’s Manhattan Project Bombshell? (Ad)

This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.

3/31/2021171,000 shares $1.01 million -5.9%1.5%0.3 $5.90
3/15/2021181,800 shares $1.33 million -5.7%1.6%0.4 $7.30
2/26/2021192,800 shares $1.38 million -6.3%1.7%0.5 $7.16
2/12/2021205,700 shares $1.98 million -1.5%1.9%0.6 $9.61
1/29/2021208,800 shares $1.94 million -15.5%2.8%0.8 $9.30
1/15/2021247,000 shares $1.99 million +31.4%3.3%1.5 $8.04
12/31/2020188,000 shares $1.17 million +28.9%2.5%1.4 $6.22
12/15/2020145,900 shares $752,844.00 -16.9%2.0%1.4 $5.16
11/30/2020175,500 shares $1.00 million +7.1%2.4%2 $5.72
11/15/2020163,800 shares $753,480.00 -11.0%2.2%1.6 $4.60
10/30/2020184,000 shares $769,120.00 +7.7%2.5%1.8 $4.18
10/15/2020170,800 shares $845,460.00 -12.7%2.3%1.2 $4.95
9/30/2020195,700 shares $929,575.00 -3.9%2.7%0.8 $4.75
9/15/2020203,700 shares $1.08 million -15.2%2.8%0.1 $5.31
8/31/2020240,100 shares $1.19 million -24.8%3.3%0.1 $4.94
8/14/2020319,100 shares $1.87 million -11.0%4.3%0.1 $5.87
7/31/2020358,700 shares $2.34 million -34.3%4.9%0.1 $6.52
7/15/2020546,200 shares $4.28 million -76.6%7.9%0.2 $7.83
6/30/20202,330,000 shares $16.57 million +692.0%36.0%0.8 $7.11
6/15/2020294,200 shares $1.11 million +20.6%4.5%1.3 $3.78
5/29/2020244,000 shares $861,320.00 -4.6%4.7%1.6 $3.53
5/15/2020255,800 shares $767,400.00 -18.9%4.9%2.5 $3.00
4/30/2020315,200 shares $1.23 million +0.4%6.1%3.6 $3.89
4/15/2020314,000 shares $1.06 million -3.7%6.1%3.7 $3.38
3/31/2020326,100 shares $1.29 million -93.4%6.3%3.9 $3.96
3/13/20204,900,300 shares $13.62 million +5.8%8.0%6.2 $2.78
2/28/20204,630,000 shares $972,300.00 +6.2%7.5%4.3 $0.21
2/14/20204,360,000 shares $1.26 million +6.1%N/A4.4 $0.29
1/31/20204,110,000 shares $1.52 million +30.5%N/A4.4 $0.37

EKSO Short Interest - Frequently Asked Questions

What is Ekso Bionics' current short interest?

Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 240,300 shares of EKSO short. Learn More on Ekso Bionics' current short interest.

Is Ekso Bionics' short interest increasing or decreasing?

Ekso Bionics saw a increase in short interest in December. As of December 31st, there was short interest totaling 240,300 shares, an increase of 92.9% from the previous total of 124,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ekso Bionics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "machinery" compare to Ekso Bionics: Sono-Tek Co. (0.10%), Tungray Technologies Inc. (0.43%), Fuel Tech, Inc. (0.60%), ZOOZ Power Ltd. (1.43%), CVD Equipment Co. (0.57%), SCHMID Group (0.59%), Greenland Technologies Holding Co. (1.23%), LiqTech International, Inc. (1.10%), Nauticus Robotics, Inc. (16.97%), Art's-Way Manufacturing Co., Inc. (9.29%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Ekso Bionics stock?

Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ekso Bionics?

A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further.

How often is Ekso Bionics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:EKSO) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners